Zhong WZ - Search Results

1

Clinicopathological features and resistance mechanisms in HIP1-ALK-rearranged lung cancer: A multicenter study.

Kang J, Deng QM, Peng KC, Li P, Zhu BT, Wang P, Chu XP, Zhong WZ, Chen HJ, Wang WX, Chen HF, Rao CZ, Xu CW, Yang JJ. Kang J, et al. Among authors: zhong wz. Genes Chromosomes Cancer. 2022 Apr;61(4):177-186. doi: 10.1002/gcc.23005. Epub 2021 Nov 1. Genes Chromosomes Cancer. 2022. PMID: 34687488

2

[Expressions of E-cadherin in non-small cell lung cancer and it correlation with prognosis].

Qiao GB, Wu YL, Ou W, Yang XN, Zhong WZ, Lin JY, Zhao J, Xie D, Guan XY. Qiao GB, et al. Among authors: zhong wz. Zhonghua Wai Ke Za Zhi. 2005 Jul 15;43(14):913-7. Zhonghua Wai Ke Za Zhi. 2005. PMID: 16083620 Chinese.

3

Epidermal growth factor receptor mutations and their correlation with gefitinib therapy in patients with non-small cell lung cancer: a meta-analysis based on updated individual patient data from six medical centers in mainland China.

Wu YL, Zhong WZ, Li LY, Zhang XT, Zhang L, Zhou CC, Liu W, Jiang B, Mu XL, Lin JY, Zhou Q, Xu CR, Wang Z, Zhang GC, Mok T. Wu YL, et al. Among authors: zhong wz. J Thorac Oncol. 2007 May;2(5):430-9. doi: 10.1097/01.JTO.0000268677.87496.4c. J Thorac Oncol. 2007. PMID: 17473659 Free article.

4

Better survival with EGFR exon 19 than exon 21 mutations in gefitinib-treated non-small cell lung cancer patients is due to differential inhibition of downstream signals.

Zhu JQ, Zhong WZ, Zhang GC, Li R, Zhang XC, Guo AL, Zhang YF, An SJ, Mok TS, Wu YL. Zhu JQ, et al. Among authors: zhong wz. Cancer Lett. 2008 Jul 8;265(2):307-17. doi: 10.1016/j.canlet.2008.02.064. Epub 2008 Apr 14. Cancer Lett. 2008. PMID: 18407408

5

Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer.

Zhong W, Yang X, Bai J, Yang J, Manegold C, Wu Y. Zhong W, et al. Eur J Cardiothorac Surg. 2008 Jul;34(1):187-95. doi: 10.1016/j.ejcts.2008.03.060. Epub 2008 May 23. Eur J Cardiothorac Surg. 2008. PMID: 18457958 Review.

6

Genetic evolution of epidermal growth factor receptor in adenocarcinoma with a bronchioloalveolar carcinoma component.

Zhong WZ, Wu YL, Yang XN, Guo AL, Su J, Zhang XC, Luo DL, Wang Z, Chen HJ, Zhou Q, Xu CR, Qiao GB, Liao RQ, Yang JJ, Mok TS. Zhong WZ, et al. Clin Lung Cancer. 2010 May;11(3):160-8. doi: 10.3816/CLC.2010.n.020. Clin Lung Cancer. 2010. PMID: 20439191

7

CYP1A1*2A polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI and its combined effects with EGFR intron 1 (CA)n polymorphism.

Nie Q, Yang XN, An SJ, Zhang XC, Yang JJ, Zhong WZ, Liao RQ, Chen ZH, Su J, Xie Z, Wu YL. Nie Q, et al. Among authors: zhong wz. Eur J Cancer. 2011 Sep;47(13):1962-70. doi: 10.1016/j.ejca.2011.04.018. Epub 2011 May 26. Eur J Cancer. 2011. PMID: 21616658

8

Relative abundance of EGFR mutations predicts benefit from gefitinib treatment for advanced non-small-cell lung cancer.

Zhou Q, Zhang XC, Chen ZH, Yin XL, Yang JJ, Xu CR, Yan HH, Chen HJ, Su J, Zhong WZ, Yang XN, An SJ, Wang BC, Huang YS, Wang Z, Wu YL. Zhou Q, et al. Among authors: zhong wz. J Clin Oncol. 2011 Aug 20;29(24):3316-21. doi: 10.1200/JCO.2010.33.3757. Epub 2011 Jul 25. J Clin Oncol. 2011. PMID: 21788562

9

Is ¹⁸F-fluorodeoxyglucose positron emission tomography-based metabolic response superior to Response Evaluation Criteria In Solid Tumors-based response after two cycles of platinum-based chemotherapy in predicting clinical outcome of untreated patients with advanced non-small cell lung cancer?

Yang JJ, Wang SX, Zhong WZ, Xu CR, Yan HH, Wu YL. Yang JJ, et al. Among authors: zhong wz. Nucl Med Commun. 2011 Dec;32(12):1113-20. doi: 10.1097/MNM.0b013e32834a8341. Nucl Med Commun. 2011. PMID: 21934546

10

EGFR mutation heterogeneity and the mixed response to EGFR tyrosine kinase inhibitors of lung adenocarcinomas.

Chen ZY, Zhong WZ, Zhang XC, Su J, Yang XN, Chen ZH, Yang JJ, Zhou Q, Yan HH, An SJ, Chen HJ, Jiang BY, Mok TS, Wu YL. Chen ZY, et al. Among authors: zhong wz. Oncologist. 2012;17(7):978-85. doi: 10.1634/theoncologist.2011-0385. Epub 2012 Jun 6. Oncologist. 2012. PMID: 22673630 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

266 results

Search Page

Filters